Literature DB >> 8608648

Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.

S R Ruuls1, S Van Der Linden, K Sontrop, I Huitinga, C D Dijkstra.   

Abstract

Macrophages constitute a large proportion of the inflammatory cells that infiltrate the central nervous system (CNS) of animals with EAE. Through the production of inflammatory mediators these infiltrating macrophages can contribute to the regulation of the immune reaction within the CNS, that eventually results in neurological deficits associated with EAE. NO, a free radical produced by macrophages and other cell types, has been put forward as such an immune mediator. In the present study we show that macrophages isolated from the CNS of Lewis rats with clinical signs of EAE produce elevated amounts of NO. We treated rats, in which EAE was induced, with N(omega) -nitro-L-arginine-methylester or N(g)-monomethyl-L-arginine, inhibitors of NO synthase, either systemically via intraperitoneal injection, or intracerebrally via a cannula placed in the lateral ventricle. Both treatments resulted in a marked aggravation of clinical signs of EAE. These data point to an important role of NO, produced by infiltrating macrophages, as an immune-suppressor in the disease process during EAE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608648      PMCID: PMC2200377          DOI: 10.1111/j.1365-2249.1996.tb08304.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  The antioxidant properties of an inhibitor of nitric oxide synthase.

Authors:  W Jessup; R T Dean
Journal:  Free Radic Biol Med       Date:  1993-04       Impact factor: 7.376

2.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

3.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ.

Authors:  R A Sobel; B W Blanchette; A K Bhan; R B Colvin
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

5.  Evidence that nitric oxide modulates drinking behaviour.

Authors:  G Calapai; F Squadrito; D Altavilla; B Zingarelli; G M Campo; M Cilia; A P Caputi
Journal:  Neuropharmacology       Date:  1992-08       Impact factor: 5.250

6.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

7.  Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level.

Authors:  J Bauer; F Berkenbosch; A M Van Dam; C D Dijkstra
Journal:  J Neuroimmunol       Date:  1993-10       Impact factor: 3.478

8.  Central serotoninergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase.

Authors:  F Squadrito; G Calapai; D Altavilla; D Cucinotta; B Zingarelli; V Arcoraci; G M Campo; A P Caputi
Journal:  Eur J Pharmacol       Date:  1994-04-01       Impact factor: 4.432

9.  Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis.

Authors:  J Zielasek; S Jung; R Gold; F Y Liew; K V Toyka; H P Hartung
Journal:  J Neuroimmunol       Date:  1995-04       Impact factor: 3.478

10.  Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells.

Authors:  J D MacMicking; D O Willenborg; M J Weidemann; K A Rockett; W B Cowden
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  16 in total

1.  Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Dusica Pavlovic; Dusan Sokolovic; Ivana Stevanovic
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

2.  Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression.

Authors:  V Trajković; V Badovinac; D Popadić; O Hadzić; M M Stojković
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

3.  Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

Authors:  Kevin Kemp; Elizabeth Gray; Elizabeth Mallam; Neil Scolding; Alastair Wilkins
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

4.  IL-5 induces proliferation and activation of microglia via an unknown receptor.

Authors:  S M Liva; J de Vellis
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

5.  Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat.

Authors:  I Huitinga; J Bauer; P J Strijbos; N J Rothwell; C D Dijkstra; F J Tilders
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 6.  Selective vulnerability of synaptic signaling and metabolism to nitrosative stress.

Authors:  Alexander A Mongin; Preeti Dohare; David Jourd'heuil
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

7.  Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis.

Authors:  Maria A Staykova; Judith T Paridaen; William B Cowden; David O Willenborg
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

8.  A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis.

Authors:  G S Scott; K I Williams; C Bolton
Journal:  Inflamm Res       Date:  1996-10       Impact factor: 4.575

9.  Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Shyi-Jou Chen; Yen-Ling Wang; Wen-Tsung Lo; Chia-Cho Wu; Chia-Wen Hsieh; Ching-Feng Huang; Yu-Hsin Lan; Chih-Chien Wang; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

10.  Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis.

Authors:  Venu Talla; Vittorio Porciatti; Vince Chiodo; Sanford L Boye; William W Hauswirth; John Guy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.